ArticleEcancermedicalscience2025
Cancer burden, its pattern and survival in Muzaffarpur: findings from first population-based cancer registry of Bihar state, India.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The first population-based cancer registries (PBCRs) in Bihar state, India was established at Muzaffarpur by the Tata Memorial Centre (TMC), Mumbai. This article presents the cancer burden, its pattern for the years 2018-2021 and population-based survival for the years 2018 cases followed till 2023. Methods: The registry follows an active method of case finding which includes visits to the hospital, diagnostic and treatment facilities centres, birth and death registration office. Cases were collected through village visit, community interaction and verbal autopsy. After quality and consistency checks by senior staff of TMC, Mumbai; data are entered into the CanReg5 software. The cancer registry has faced several challenges in data collection, such as poor maintenance of medical records noncooperation of the hospital and patient's relatives reluctant to share the cancer case information. Most patients travel long distances for diagnosis and treatment. The challenges faced by the registry were overcome with the help of the administrative support of the district authorities.The rates were calculated using standard registry methods. The survival of 2018 incidence cases (followed till 31st December 2023) was calculated by using the Kaplan-Meier and Pohar Perme method. Results: In the period 2018-2021, a total of 2,916 cancer cases (Male: 1,436 (49.2%) and Female: 1,480 (50.7%)) were registered. The incidence rates for males and females were 40.2 and 46.8 per 100,000 population, respectively. Whereas 2,076 cancer deaths (Male: 1,049 (50.5%) and Female: 1,027 (49.5%)) were registered and mortality rates were 29.6 and 32.6 per 100,000 for males and females, respectively. The leading cancer sites for males are mouth (AAR 6.0), tongue (2.6), prostate (2.0), gallbladder (1.9), liver (1.6); and for females, breast (11.1), cervix uteri (6.3), gallbladder (5.2), lung (1.9) and ovary (1.6).Among men, 5-year age-standardised relative survival (age 0-74 years) of mouth, prostate and tongue cancer cases were 25.59%, 30.41% and 31.90%, respectively. Similarly, among females, it was 32.39% of breast, 20.73% of cervix uteri. None of the gallbladder cases survived after 3 year and 5 years of diagnosis. Conclusion: The population-based cancer registry has successfully generated good-quality data, which can be utilised to plan cancer control programs, enhance the infrastructure for cancer care and facilitate etiological research in this population. Given the poor survival of leading sites in Muzaffarpur, emphasis must be laid on strengthening effective cancer control strategies for these cancers.Due to several challenges faced by the registry, we have noted underreporting. In the coming years, due to improvements in the infrastructure and raising awareness about the use of registry data in planning cancer care services, we are expecting an improvement in cancer registration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.